Ga
Not verified

Galderma

What we write about

BiotechnologyHealthIndustriaPharmaceuticalsSanità
11/12/2025
Multimedia
Industria
Cosmetics
Forecourt retailing
Health
Medicine - various
Pharmaceuticals
Biotechnology
Galderma Announces First Patient Enrollment in Study to Assess Nemolizumab in Adults With Chronic Pruritus of Unknown Origin
1.00
05/12/2025
Multimedia
Industria
Cosmetics
Forecourt retailing
Medical and health
Health
Sanità
Galderma Opens up New Chapter for Sculptra® with MDR Certification and New Expanded Indication for Body
1.00
04/12/2025
Stocks and shares
Associations / Professional
Health
Sanità
Finance
Pharmaceuticals
Biotechnology
Galderma Secures ‘BBB’ Credit Rating With Positive Outlook from S&P Global Ratings
1.00
24/09/2025
Multimedia
Fairs
Industria
Eventi
Cosmetics
Forecourt retailing
Health
Medicine - various
Sanità
Biotechnology
AMWC Dubai: Galderma Demonstrates Injectable Aesthetics Leadership Through Updates on Its Scientific Innovations and Community Education
1.00
18/09/2025
Labour market
Industria
Biotechnology
Health
Magazines / Gossip
Cosmetics
Medicine - various
Forecourt retailing
Show business
Sanità
Galderma Launches Transformative Skincare Segment With Cetaphil’s New Skin Activator Hydrating & Firming Line, in Partnership With Actor and Filmmaker Mariska Hargitay
1.00
11/09/2025
Cosmetics
Forecourt retailing
Health
Sanità
Pharmaceuticals
Eventi
Industria
EADV 2025: Galderma Reinforces Leadership in Dermatology With Latest Advances in Sensitive Skin and Itch
1.00
10/09/2025
Sanità
Health
Cosmetics
Forecourt retailing
Pharmaceuticals
Industria
Galderma Launches Alastin® in China, Supporting the Skin’s Natural Regenerative Abilities in a Rapidly Expanding Market
1.00
24/07/2025
stock market
Forecourt retailing
Stocks and shares
Industria
WEB AND SOCIAL NETWORK
Sanità
Health
Cosmetics
Pharmaceuticals
Galderma Delivers Record First Half 2025 Net Sales of 2.448 Billion USD and 12.2% Year-on-Year Growth at Constant Currency, Raises Full-Year Top-Line Guidance
1.00
25/06/2025
Health
Sanità
Medicine - various
Scienza
Pharmaceuticals
Biotechnology
Industria
Galderma Initiates Two New Clinical Trials Investigating Nemolizumab in Patients With Systemic Sclerosis and Chronic Pruritus of Unknown Origin
1.00

Contact details

Social Media

Followers
0
Compatibility
0